Introduction
Deep sclerectomy (DS) has become an alternative to trabeculectomy or other glaucoma procedures. As a nonpenetrating procedure, DS is generally considered to have fewer adverse effects than trabeculectomy (1, 2) . Many of these adverse effects after glaucoma surgery are related to decreasing intraocular pressure (IOP). Persistent hypotony is more common after trabeculectomy (3) than after DS (2, 4) , and this can lead to macular edema (5) . A recent review highlighted changes in ocular biometrics after trabeculectomy (6) . Low IOP after trabeculectomy may affect anterior chamber depth and axial length (7, 8) . Many of these postoperative changes can be overlooked, however, since many eyes have decreased Indications for surgery were IOP considered too high for the patient (24 eyes) and progression of visual field damage (11 eyes).
Deep sclerectomy was performed under retrobulbar anesthesia. A fornix-based conjunctival flap was made in the superior hemisphere. A superficial rectangular scleral flap approximately one-third of the scleral thickness was dissected anteriorly until clear cornea. Mitomycin C (MMC) was used when the surgeon considered it necessary in order to achieve desired IOP reduction. When intraoperative application of MMC was necessary, polyvinyl alcohol sponges soaked in 0.4 mg/mL MMC were instilled under the conjunctiva for 3 minutes, after which the subconjunctival space was carefully washed with 20 mL of balanced salt solution. A smaller deep flap was created, and dissection was continued anteriorly to the canal of Schlemm and further anteriorly to separate Descemet membrane from the corneal stroma to create trabeculo-Descemet window. The inner wall of the Schlemm canal was peeled off with forceps and the deep flap excised. A collagen implant (Aquaflow®; Staar Surgical) was placed on the exposed stromal bed and secured with one 10-0 polyamide (Ethilon®; Ethicon Inc.) suture. The flap was sutured loosely from the posterior corners with 10/0 nylon (Alcon Laboratories). Limbal opening of conjunctiva was closed with 2 interrupted sutures and radial opening with continuous suture using 9/0 polyglactin (Vicryl®; Johnson & Johnson). A subconjunctival triamcinolone injection was given inferiorly.
Patients were examined by an ophthalmologist preoperatively, as well as 1 week, 2 weeks, and 4 weeks postoperatively. On all follow-up visits, we determined the subjective refraction, performed ophthalmologic examinations with IOP measurement by Goldmann applanation tonometer, measured anterior chamber depth (ACD) and axial length (AL) with IOL Master (Carl Zeiss Meditec AG), and evaluated the corneal shape by a corneal Galilei Dual Scheimpflug Analyzer (SIS Surgical Instrument Systems AG). We used the steepest and flattest K-values, SimKmax and SimKmin, respectively, as measurements of corneal curvature. As corneal thickness, we used the central measurement from corneal topography. As corneal volume, we used volume of cornea within central 8 mm diameter from corneal topography. Average corneal power (ACP) in diopters within a central 3-mm diameter was measured, as were inferior-superior index, surface regulatory index, surface asymmetry index, and irregular asymmetry index. Corneal Scheimpflug images were analyzed in a masked fashion by a cornea specialist.
We determined the angle between the scleral flap and the SimKaxis preoperatively and postoperatively, and we measured the angle of SimKaxis by Scheimpflug Analyzer. This angle was compared to the angle of the scleral flap as retrieved from patient records. The angle of the flap was 90 degrees when the flap was made superiorly and 45 degrees or 135 degrees when the flap was superotemporal or superonasal.
We measured macular volume and foveal thickness by Stratus optical coherence tomography (OCT) (Stratus OCT model 3000; Carl Zeiss Meditec Inc.). Macular volume was reported as the OCT measurement of macular volume within a 1-mm radius from the foveal center. Foveal thickness was the average thickness of this central part of the macula.
In a masked fashion, a retina specialist (A.M.E.H.) analyzed OCT measurements for the presence of cystic macular edema/fluid and choroidal folds. A complete set of 6 radial scans was required in order to make this analysis.
We performed statistical analysis with SPSS 22 for Windows. Summary statistics are presented as mean (±SD). A p-value of less than 0.05 was considered statistically significant. In the analysis of results, the Student t-test and Wilcoxon signed-rank test were used when appropriate. The study followed the tenets of the Declaration of 
Results
This prospective study enrolled 35 eyes of 35 patients scheduled for DS in Helsinki University Central Hospital. Mitomycin C was instilled in 28 eyes (80%) intraoperatively. Preoperative IOP was 20.8 mm Hg (5.1) and number of glaucoma medications in use preoperatively was 3.2 (0.9) (Tab. I). Preoperative IOP was higher when MMC was used: 21.7 mm Hg (5.1) compared to 17.2 mm Hg (4.8) without MMC (p = 0.035). For results, see Figure 1 and Table II. The mean IOP was lower than its preoperative values on all follow-up visits. Number of glaucoma medications 3.2 ± 0.9
Visual acuity, logMAR 0.14 ± 0.1
Axial length, mm 24.12 ± 1.8
Central corneal thickness, μm 547 ± 25 Two weeks after the operation, 4 patients had signs of macular folds on OCT and an IOP of 4 mm Hg or lower. Visual acuities of these patients in Snellen lines were 0.5, 0.5, 0.6, and 0.9 preoperatively, and 0.5, 0.7, 0.6, and 0.5 2 weeks postoperatively. Four weeks after the operation, 2 of these patients had signs of macular folds within a 3 mm radius of the fovea and an IOP of 4 mm Hg, both with visual acuity of 0.9 in Snellen lines.
Patients without macular folds 2 weeks after the operation had a median visual acuity of 0.8 (range 0.3-1.0) in Snellen lines. Preoperatively, 20.6% of these patients had signs of an epiretinal membrane on OCT.
None of the patients had an IOP lower than 4 mm Hg 1 month postoperatively.
We did not have a predetermined IOP level in mm Hg as a target in the early postoperative period. Five patients were considered to have IOPs that were too high and underwent YAG-laser goniopuncture (GP) during the 4-week follow-up. The IOP of these patients before GP was 26.8 mm Hg (8.7) and 13.0 (5.8) (p = 0.053) after GP.
One patient had a postoperative hyphema, one needed resuturing of the conjunctiva, and needling was necessary for one patient. 
Discussion
As expected, IOP decreased after the operation (4, 9, 11). Decrease in visual acuity was found 1 and 2 weeks after the operation, but it recovered to the preoperative level 4 weeks postoperatively. Even earlier recovery of visual acuity has been reported with DS (1). Results are mean ± SD or n (%); p as compared to preoperative values. ACD = anterior chamber depth; ACP = average corneal power; AL = axial length; BCVA = best-corrected visual acuity; CCT = central corneal thickness; IOP = intraocular pressure; SimKmax = steeper simulated K-value; SimKmin = flatter simulated K-value; SimKaxis = axis of flatter axis.
Decrease in AL occurred at all postoperative visits, with change in AL related to amount of IOP lowering. Similar findings have emerged after trabeculectomy when AL has been measured optically by IOL-Master (7, 8) and by ultrasound (12) . In our study with DS, ACD was unaffected postoperatively. In one study of trabeculectomy, shallowing of the ACD was correlated with IOP reduction (7) .
Change in AL, but not in ACD, could be explained by changes in diameters of the posterior segment, i.e., choroidal thickness. Choroidal thickness is known to change after trabeculectomy; choroidal thickness increases when IOP decreases postoperatively and at the same time AL may decrease (13) . In the study of Saeedi et al (13) , half of the reduction in AL was due to thickening of the choroid, and the rest was a true change in AL. In our study, no measurements of choroidal thickness were available. What would be interesting to study is whether lowering in IOP has the same effect on the choroid after DS as it has after trabeculectomy.
Corneal curvature of the steeper meridian, SimKmax, increased significantly after surgery, and this change persisted until 4 weeks postoperatively. Similarly, average corneal power increased postoperatively. A smaller change has been reported in corneal astigmatism after nonpenetrating glaucoma surgery than after trabeculectomy (14) . Also, changes in corneal power have been reported after trabeculectomy (15) . The scleral flap was sutured loosely during the operation and the direction of corneal astigmatism did not change towards or away from the scleral flap.
Two patients had corneal Scheimpflug measurements obtained 1 week after GP. While GP could theoretically affect the corneal curvature, it could have been informative to measure corneal curvature just before and after GP.
In our study, CCT was decreased postoperatively throughout the follow-up period. A recent study of patients with POAG after trabeculectomy showed that CCT was significantly decreased by 5-6 µm 1 month postoperatively (16) . The CCT was also decreased after trabeculotomy in a study of congenital glaucoma patients (17) . One possible explanation of lower CCT after glaucoma surgery may be that lowering IOP alters endothelial function, and this leads to less aqueous accumulating in corneal structures. Creating the Descemet window during DS may induce iatrogenic changes in corneal structure. A rare complication of hemorrhagic detachment of Descemet membrane has been reported after uneventful DS (18) .
Galilei Dual Scheimpflug Analyzer has excellent repeatability between CCT measurements with 95% limits of agreement between +5.72 μm and -9.22 μm in eyes without surgery (19) . However, measurement of corneal shape with Scheimpflug imaging was not easy after surgery. With low postoperative IOP, the repeatability of Scheimpflug measurements can be poor. Moreover, the formation of a filtering bleb can change the surface of a corneal tear film, at least in the immediate postoperative period. These can also explain some of the changes apparent in corneal dimensions. It would have been interesting to find the effect of DS on anterior chamber angle and anterior chamber volume as measured by the Scheimpflug Analyzer. However, with the Scheimpflug Analyzer over 50% of anterior chamber angle and anterior chamber volume preoperative measurements were unreliable.
After DS, the incidence of macular edema has been reported to be 3.5% (5) . We noted no change in macular volume or foveal thickness postoperatively. Four patients had macular folds postoperatively with good visual acuities. This is in concordance with studies reporting that DS has fewer ocular fundus-related side effects than does trabeculectomy (2) . The decrease in IOP occurs more slowly after DS, which can explain why almost no macular changes were found. After trabeculectomy, macular thickness increases during the first postoperative months but then decreases to its preoperative thickness (7) . Glaucoma surgery can cause retinal bleeding in the immediate postoperative period. This ocular decompression retinopathy also has been reported after DS with MMC (20) . After follow-up, retinal hemorrhages were absorbed and visual acuity returned to the preoperative level.
Study results may have been affected by the reduced ability of patients to fixate during corneal Scheimpflug or OCT measurements. After IOP-lowering surgery, poor fixation, perhaps compromised by visual field defects, may have reduced their BCVA.
In conclusion, we show that after DS, some changes occur in corneal curvature and ocular dimensions. These changes are relatively small and may not explain the lowered visual acuity in the immediate postoperative period. Compared to findings for trabeculectomy, the amount of postoperative change seems to be low. After DS, macular dimensions did not change.
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